{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:25:52Z","timestamp":1778801152352,"version":"3.51.4"},"reference-count":72,"publisher":"Japanese Society for Hygiene","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Environ Health Prev Med","Environ. Health Prev. Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1265\/ehpm.24-00365","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T22:12:16Z","timestamp":1741731136000},"page":"17-17","source":"Crossref","is-referenced-by-count":4,"title":["A 4-year cohort study of the effects of PNPLA3 rs738409 genotypes on liver fat and fibrosis and gut microbiota in a non-fatty liver population"],"prefix":"10.1265","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5569-7093","authenticated-orcid":false,"given":"Satoshi","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hematology and Clinical Immunology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikara","family":"Iino","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hematology and Clinical Immunology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Sasada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hematology and Clinical Immunology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Furusawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hematology and Clinical Immunology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hematology and Clinical Immunology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Preemptive Medicine, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Mikami","sequence":"additional","affiliation":[{"name":"Department of Preemptive Medicine, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsaku","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Preemptive Medicine, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Nakaji","sequence":"additional","affiliation":[{"name":"Department of Preemptive Medicine, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotake","family":"Sakuraba","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hematology and Clinical Immunology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"335","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Castillo-N\u00fa\u00f1ez Y, Almeda-Valdes P, Gonz\u00e1lez-G\u00e1lvez G, Arechavaleta-Granell MDR. Metabolic dysfunction-associated steatotic liver disease and atherosclerosis. Curr Diab Rep. 2024;24:158\u201366. https:\/\/link.springer.com\/article\/10.1007\/s11892-024-01542-6.","DOI":"10.1007\/s11892-024-01542-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Younossi ZM, Gramlich T, Matteoni CA, Boparai N, McCullough AJ. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol. 2004;2:262\u20135. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S154235650400014X?via%3Dihub.","DOI":"10.1016\/S1542-3565(04)00014-X"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Leite NC, Villela-Nogueira CA, Cardoso CR, Salles GF. Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment. World J Gastroenterol. 2014;20:8377\u201392. https:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i26\/8377.htm.","DOI":"10.3748\/wjg.v20.i26.8377"},{"key":"4","unstructured":"4. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966\u201386. https:\/\/journals.lww.com\/hep\/fulltext\/2023\/12000\/a_multisociety_delphi_consensus_statement_on_new.28.aspx."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7:851\u201361. https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S2468125322001650?via%3Dihub.","DOI":"10.1016\/S2468-1253(22)00165-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461\u20135. https:\/\/www.nature.com\/articles\/ng.257.","DOI":"10.1038\/ng.257"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kawaguchi T, Sumida Y, Umemura A, Matsuo K, Takahashi M, Takamura T, et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS One. 2012;7:e38322. https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0038322.","DOI":"10.1371\/journal.pone.0038322"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kotronen A, Johansson LE, Johansson LM, Roos C, Westerbacka J, Hamsten A, et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia. 2009;52:1056\u201360. https:\/\/link.springer.com\/article\/10.1007\/s00125-009-1285-z.","DOI":"10.1007\/s00125-009-1285-z"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kantartzis K, Peter A, Machicao F, Machann J, Wagner S, K\u00f6nigsrainer I, et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes. 2009;58:2616\u201323. https:\/\/diabetesjournals.org\/diabetes\/article\/58\/11\/2616\/15110\/Dissociation-Between-Fatty-Liver-and-Insulin.","DOI":"10.2337\/db09-0279"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Goran MI, Walker R, Le KA, Mahurkar S, Vikman S, Davis JN, et al. Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents. Diabetes. 2010;59:3127\u201330. https:\/\/diabetesjournals.org\/diabetes\/article\/59\/12\/3127\/26309\/Effects-of-PNPLA3-on-Liver-Fat-and-Metabolic.","DOI":"10.2337\/db10-0554"},{"key":"11","unstructured":"11. Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011;7:e1001324. https:\/\/journals.plos.org\/plosgenetics\/article?id=10.1371\/journal.pgen.1001324."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Li J, Zhao Y, Zhang H, Hua W, Jiao W, Du X, et al. Contribution of Rs780094 and Rs1260326 Polymorphisms in GCKR Gene to Non-alcoholic Fatty Liver Disease: A Meta-Analysis Involving 26,552 Participants. Endocr Metab Immune Disord Drug Targets. 2021;21:1696\u2013708. https:\/\/www.eurekaselect.com\/article\/111887.","DOI":"10.2174\/1871530320999201126202706"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Li L, Wang SJ, Shi K, Chen D, Jia H, Zhu J. Correlation between MTP -493G>T polymorphism and non-alcoholic fatty liver disease risk: a meta-analysis. Genet Mol Res. 2014;13:10150\u201361. https:\/\/www.funpecrp.com.br\/gmr\/year2014\/vol13-4\/pdf\/gmr4220.pdf.","DOI":"10.4238\/2014.December.4.9"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Dong H, Wang J, Li C, Hirose A, Nozaki Y, Takahashi M, et al. The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population. J Hepatol. 2007;46:915\u201320. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168827807000359?via%3Dihub.","DOI":"10.1016\/j.jhep.2006.12.012"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Musso G, Cipolla U, Cassader M, Pinach S, Saba F, De Michieli F, et al. TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD. J Lipid Res. 2017;58:1221\u20139. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022227520310142?via%3Dihub.","DOI":"10.1194\/jlr.M075028"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tong M, Wang F. APOC3rs2854116, PNPLA3rs738409, and TM6SF2rs58542926 polymorphisms might influence predisposition of NAFLD: A meta-analysis. IUBMB Life. 2020;72:1757\u201364. https:\/\/iubmb.onlinelibrary.wiley.com\/doi\/10.1002\/iub.2302.","DOI":"10.1002\/iub.2302"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Al-Serri A, Anstee QM, Valenti L, Nobili V, Leathart JB, Dongiovanni P, et al. The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. J Hepatol. 2012;56:448\u201354. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168827811005356?via%3Dihub.","DOI":"10.1016\/j.jhep.2011.05.029"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Stender S, Smagris E, Lauridsen BK, Kofoed KF, Nordestgaard BG, Tybjaerg-Hansen A, et al. Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride. Hepatology. 2018;67:2182\u201395. https:\/\/journals.lww.com\/hep\/abstract\/2018\/06000\/relationship_between_genetic_variation_at_ppp1r3b.20.aspx.","DOI":"10.1002\/hep.29751"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wang BF, Wang Y, Ao R, Tong J, Wang BY. AdipoQ T45 G and G276 T Polymorphisms and Susceptibility to Nonalcoholic Fatty Liver Disease Among Asian Populations: A Meta-Analysis and Meta-Regression. J Clin Lab Anal. 2016;30:47\u201357. https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcla.21814.","DOI":"10.1002\/jcla.21814"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hotta K, Yoneda M, Hyogo H, Ochi H, Mizusawa S, Ueno T, et al. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. BMC Med Genet. 2010;11:172. https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-11-172.","DOI":"10.1186\/1471-2350-11-172"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nishioji K, Mochizuki N, Kobayashi M, Kamaguchi M, Sumida Y, Nishimura T, et al. The impact of PNPLA3 rs738409 genetic polymorphism and weight gain \u226510 kg after age 20 on non-alcoholic fatty liver disease in non-obese Japanese individuals. PLoS One. 2015;10:e0140427. https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0140427.","DOI":"10.1371\/journal.pone.0140427"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kawaguchi T, Shima T, Mizuno M, Mitsumoto Y, Umemura A, Kanbara Y, et al. Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers. PLoS One. 2018;13:e0185490. https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0185490.","DOI":"10.1371\/journal.pone.0185490"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Blesl A, Stadlbauer V. The gut-liver axis in cholestatic liver diseases. Nutrients. 2021;13:1018. https:\/\/www.mdpi.com\/2072-6643\/13\/3\/1018.","DOI":"10.3390\/nu13031018"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Aron-Wisnewsky J, Vigliotti C, Witjes J, Le P, Holleboom AG, Verheij J, et al. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat Rev Gastroenterol Hepatol. 2020;17:279\u201397. https:\/\/www.nature.com\/articles\/s41575-020-0269-9.","DOI":"10.1038\/s41575-020-0269-9"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Duarte SM, Stefano JT, Oliveira CP. Microbiota and nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis (NAFLD\/NASH). Ann Hepatol. 2019;18:416\u201321. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S166526811930050X?via%3Dihub.","DOI":"10.1016\/j.aohep.2019.04.006"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Gundogdu A, Nalbantoglu U. Human genome-microbiome interaction: metagenomics frontiers for the aetiopathology of autoimmune diseases. Microb Genom. 2017;3:e000112. https:\/\/www.microbiologyresearch.org\/content\/journal\/mgen\/10.1099\/mgen.0.000112.","DOI":"10.1099\/mgen.0.000112"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Priya S, Burns MB, Ward T, Mars RA, Adamowicz B, Lock EF, et al. Identification of shared and disease-specific host gene\u2013microbiome associations across human diseases using multi-omic integration. Nat Microbiol. 2022;7:780\u201395. https:\/\/www.nature.com\/articles\/s41564-022-01121-z.","DOI":"10.1038\/s41564-022-01121-z"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Cuomo P, Capparelli R, Alifano M, Iannelli A, Iannelli D. Gut microbiota host\u2013gene interaction. Int J Mol Sci. 2022;23:13717. https:\/\/www.mdpi.com\/1422-0067\/23\/22\/13717.","DOI":"10.3390\/ijms232213717"},{"key":"29","unstructured":"29. Ha S, Wong VWS, Zhang X, Yu J. Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma. Gut. 2024. https:\/\/gut.bmj.com\/content\/early\/2024\/06\/28\/gutjnl-2024-332398."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Tomofuji Y, Kishikawa T, Sonehara K, Maeda Y, Ogawa K, Kawabata S, et al. Analysis of gut microbiome, host genetics, and plasma metabolites reveals gut microbiome-host interactions in the Japanese population. Cell Rep. 2023;42. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2211124723013360?via%3Dihub.","DOI":"10.1016\/j.celrep.2023.113324"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ishida S, Kato K, Tanaka M, Odamaki T, Kubo R, Mitsuyama E, et al. Genome-wide association studies and heritability analysis reveal the involvement of host genetics in the Japanese gut microbiota. Commun Biol. 2020;3:686. https:\/\/www.nature.com\/articles\/s42003-020-01416-z.","DOI":"10.1038\/s42003-020-01416-z"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Nakaji S, Ihara K, Sawada K, Parodi S, Umeda T, Takahashi I, et al. Social innovation for life expectancy extension utilizing a platform-centered system used in the Iwaki health promotion project: A protocol paper. SAGE Open Med. 2021;9:20503121211002606. https:\/\/journals.sagepub.com\/doi\/10.1177\/20503121211002606.","DOI":"10.1177\/20503121211002606"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de L\u00e9dinghen V, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66:1022\u201330. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168827816307553?via%3Dihub.","DOI":"10.1016\/j.jhep.2016.12.022"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kawai Y, Mimori T, Kojima K, Nariai N, Danjoh I, Saito R, et al. Japonica array: improved genotype imputation by designing a population-specific SNP array with 1070 Japanese individuals. J Hum Genet. 2015;60:581\u20137. https:\/\/www.nature.com\/articles\/jhg201568.","DOI":"10.1038\/jhg.2015.68"},{"key":"35","unstructured":"35. Nagasaki M, Yasuda J, Katsuoka F, Nariai N, Kojima K, Kawai Y, et al. Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals. Nat Commun. 2015;6:8018. https:\/\/www.nature.com\/articles\/ncomms9018."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Takahashi S, Tomita J, Nishioka K, Hisada T, Nishijima M. Development of a prokaryotic universal primer for simultaneous analysis of Bacteria and Archaea using next-generation sequencing. PLoS One. 2014;9:e105592. https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0105592.","DOI":"10.1371\/journal.pone.0105592"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Rognes T, Flouri T, Nichols B, Quince C, Mah\u00e9 F. VSEARCH: a versatile open source tool for metagenomics. PeerJ. 2016;4:e2584. https:\/\/peerj.com\/articles\/2584\/.","DOI":"10.7717\/peerj.2584"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73:5261\u20137. https:\/\/journals.asm.org\/doi\/10.1128\/aem.00062-07.","DOI":"10.1128\/AEM.00062-07"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:1\u201318. https:\/\/genomebiology.biomedcentral.com\/articles\/10.1186\/gb-2011-12-6-r60.","DOI":"10.1186\/gb-2011-12-6-r60"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Seko Y, Yamaguchi K, Shima T, Iwaki M, Takahashi H, Kawanaka M, et al. The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: A multicentre cohort study. Liver Int. 2023;43:2210\u20139. https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.15678.","DOI":"10.1111\/liv.15678"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Wang Y, Kory N, BasuRay S, Cohen JC, Hobbs HH. PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice. Hepatology. 2019;69:2427\u201341. https:\/\/journals.lww.com\/hep\/abstract\/2019\/06000\/aberrant_super_enhancer_landscape_in_human.17.aspx.","DOI":"10.1002\/hep.30583"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Pingitore P, Dongiovanni P, Motta BM, Meroni M, Lepore SM, Mancina RM, et al. PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis. Hum Mol Genet. 2016;25:5212\u201322. https:\/\/academic.oup.com\/hmg\/article\/25\/23\/5212\/2580673.","DOI":"10.1093\/hmg\/ddw341"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Pirazzi C, Valenti L, Motta BM, Pingitore P, Hedfalk K, Mancina RM, et al. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells. Hum Mol Genet. 2014;23:4077\u201385. https:\/\/academic.oup.com\/hmg\/article\/23\/15\/4077\/2900760?login=true.","DOI":"10.1093\/hmg\/ddu121"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Wang CW, Lin HY, Shin SJ, Yu ML, Lin ZY, Dai CY, et al. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. Liver Int. 2011;31:1326\u201331. https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2011.02526.x.","DOI":"10.1111\/j.1478-3231.2011.02526.x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Koo BK, Joo SK, Kim D, Bae JM, Park JH, Kim JH, et al. Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2018;33:1277\u201385. https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jgh.14056.","DOI":"10.1111\/jgh.14056"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Jarasvaraparn C, Vilar-Gomez E, Yates KP, Wilson LA, Neuschwander-Tetri B, Loomba R, et al. Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLD. Clin Gastroenterol Hepatol. 2024;22:1024\u201336.e2. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1542356523010418?via%3Dihub.","DOI":"10.1016\/j.cgh.2023.12.009"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Rosso C, Caviglia GP, Birolo G, Armandi A, Pennisi G, Pelusi S, et al. Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2023;21:3314\u201321.e3. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1542356523003245?via%3Dihub.","DOI":"10.1016\/j.cgh.2023.04.024"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Takeuchi F, Yamamoto K, Katsuya T, Nabika T, Sugiyama T, Fujioka A, et al. Association of genetic variants for susceptibility to obesity with type 2 diabetes in Japanese individuals. Diabetologia. 2011;54:1350\u20139. https:\/\/link.springer.com\/article\/10.1007\/s00125-011-2086-8.","DOI":"10.1007\/s00125-011-2086-8"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Hotta K, Nakamura M, Nakamura T, Matsuo T, Nakata Y, Kamohara S, et al. Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population. J Hum Genet. 2009;54:727\u201331. https:\/\/www.nature.com\/articles\/jhg2009106.","DOI":"10.1038\/jhg.2009.106"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Takezawa J, Yamada K, Morita A, Aiba N, Watanabe S. Preproghrelin gene polymorphisms in obese Japanese: Association with diabetes mellitus in men and with metabolic syndrome parameters in women. Obes Res Clin Pract. 2009;3:179\u201391. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1871403X09000362?via%3Dihub.","DOI":"10.1016\/j.orcp.2009.04.003"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Iino C, Endo T, Mikami K, Hasegawa T, Kimura M, Sawada N, et al. Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study. Hepatol Int. 2019;13:748\u201356. https:\/\/link.springer.com\/article\/10.1007\/s12072-019-09987-8.","DOI":"10.1007\/s12072-019-09987-8"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Oka A, Sartor RB. Microbial-based and microbial-targeted therapies for inflammatory bowel diseases. Dig Dis Sci. 2020;65:757\u201388. https:\/\/link.springer.com\/article\/10.1007\/s10620-020-06090-z.","DOI":"10.1007\/s10620-020-06090-z"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Fukui H. Role of gut dysbiosis in liver diseases: what have we learned so far? Diseases. 2019;7:58. https:\/\/www.mdpi.com\/2079-9721\/7\/4\/58.","DOI":"10.3390\/diseases7040058"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Ferolla SM, Armiliato GN, Couto CA, Ferrari TC. The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease. Nutrients. 2014;6:5583\u201399. https:\/\/www.mdpi.com\/2072-6643\/6\/12\/5583.","DOI":"10.3390\/nu6125583"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Liu J, Fu Y, Zhang H, Wang J, Zhu J, Wang Y, et al. The hepatoprotective effect of the probiotic Clostridium butyricum against carbon tetrachloride-induced acute liver damage in mice. Food Funct. 2017;8:4042\u201352. https:\/\/pubs.rsc.org\/en\/content\/articlelanding\/2017\/fo\/c7fo00355b.","DOI":"10.1039\/C7FO00355B"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Sato S, Iino C, Sasada T, Soma G, Furusawa K, Yoshida K, et al. Epidemiological Study on the Interaction between the PNPLA3 (rs738409) and Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease. Genes (Basel). 2024;15. https:\/\/www.mdpi.com\/2073-4425\/15\/9\/1172.","DOI":"10.3390\/genes15091172"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Nishijima S, Suda W, Oshima K, Kim SW, Hirose Y, Morita H, et al. The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res. 2016;23:125\u201333. https:\/\/academic.oup.com\/dnaresearch\/article\/23\/2\/125\/1745357?login=true.","DOI":"10.1093\/dnares\/dsw002"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Aoki R, Onuki M, Hattori K, Ito M, Yamada T, Kamikado K, et al. Commensal microbe-derived acetate suppresses NAFLD\/NASH development via hepatic FFAR2 signalling in mice. Microbiome. 2021;9:188. https:\/\/microbiomejournal.biomedcentral.com\/articles\/10.1186\/s40168-021-01125-7.","DOI":"10.1186\/s40168-021-01125-7"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Hrncir T, Hrncirova L, Kverka M, Hromadka R, Machova V, Trckova E, et al. Gut microbiota and NAFLD: pathogenetic mechanisms, microbiota signatures, and therapeutic interventions. Microorganisms. 2021;9:957. https:\/\/www.mdpi.com\/2076-2607\/9\/5\/957.","DOI":"10.3390\/microorganisms9050957"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology. 2013;57:601\u20139. https:\/\/aasldpubs.onlinelibrary.wiley.com\/doi\/10.1002\/hep.26093.","DOI":"10.1002\/hep.26093"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Zhang J, Song L, Wang Y, Liu C, Zhang L, Zhu S, et al. Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats. J Gastroenterol Hepatol. 2019;34:1368\u201376. https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jgh.14536.","DOI":"10.1111\/jgh.14536"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One. 2012;7:e39743. https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0039743.","DOI":"10.1371\/journal.pone.0039743"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Wang T, Sternes PR, Guo XK, Zhao H, Xu C, Xu H. Autoimmune diseases exhibit shared alterations in the gut microbiota. Rheumatology (Oxford). 2024;63:856\u201365. https:\/\/academic.oup.com\/rheumatology\/article\/63\/3\/856\/7226506?login=true.","DOI":"10.1093\/rheumatology\/kead364"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Ma X, Lu X, Zhang W, Yang L, Wang D, Xu J, et al. Gut microbiota in the early stage of Crohn\u2019s disease has unique characteristics. Gut Pathog. 2022;14:46. https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-022-00521-0.","DOI":"10.1186\/s13099-022-00521-0"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. He B, Sheng C, Yu X, Zhang L, Chen F, Han Y. Alterations of gut microbiota are associated with brain structural changes in the spectrum of Alzheimer\u2019s disease: the SILCODE study in Hainan cohort. Front Aging Neurosci. 2023;15:1216509. https:\/\/www.frontiersin.org\/journals\/aging-neuroscience\/articles\/10.3389\/fnagi.2023.1216509\/full.","DOI":"10.3389\/fnagi.2023.1216509"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Zhang Q, Zou R, Guo M, Duan M, Li Q, Zheng H. Comparison of gut microbiota between adults with autism spectrum disorder and obese adults. PeerJ. 2021;9:e10946. https:\/\/peerj.com\/articles\/10946\/.","DOI":"10.7717\/peerj.10946"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Ha S, Wong VW, Zhang X, Yu J. Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma. Gut. 2024;74:141\u201352. https:\/\/gut.bmj.com\/content\/74\/1\/141.","DOI":"10.1136\/gutjnl-2024-332398"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Monga Kravetz A, Testerman T, Galuppo B, Graf J, Pierpont B, Siebel S, et al. Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth. J Clin Endocrinol Metab. 2020;105:e3575\u201385. https:\/\/academic.oup.com\/jcem\/article\/105\/10\/e3575\/5860169.","DOI":"10.1210\/clinem\/dgaa382"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Lin YP, Tsai YC, Tsai MJ, Huang PY, Chen CH, Yao CC, et al. Effect of gut microbiota and PNPLA3 polymorphisms on nonalcoholic fatty liver disease in lean and obese individuals. Adv Dig Med. 2024;11:129\u201339. https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/aid2.13367.","DOI":"10.1002\/aid2.13367"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. B\u00e4ckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101:15718\u201323. https:\/\/www.pnas.org\/doi\/full\/10.1073\/pnas.0407076101.","DOI":"10.1073\/pnas.0407076101"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Spor A, Koren O, Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol. 2011;9:279\u201390. https:\/\/www.nature.com\/articles\/nrmicro2540.","DOI":"10.1038\/nrmicro2540"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Parthasarathy G, Revelo X, Malhi H. Pathogenesis of Nonalcoholic Steatohepatitis: An Overview. Hepatol Commun. 2020;4:478\u201392. https:\/\/journals.lww.com\/hepcomm\/fulltext\/2020\/04000\/pathogenesis_of_nonalcoholic_steatohepatitis__an.3.aspx.","DOI":"10.1002\/hep4.1479"}],"container-title":["Environmental Health and Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ehpm\/30\/0\/30_24-00365\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T05:12:47Z","timestamp":1742015567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ehpm\/30\/0\/30_24-00365\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":72,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1265\/ehpm.24-00365","relation":{},"ISSN":["1342-078X","1347-4715"],"issn-type":[{"value":"1342-078X","type":"print"},{"value":"1347-4715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"24-00365"}}